(Q35766450)

10 August 2017

1 reference

title

Positron emission tomography: an advanced nuclear medicine imaging technique from research to clinical practice (English)

1 reference

positron emission tomography

10 August 2017

main subject

1 reference

Rakesh Kumar

1

1 reference

10 August 2017

Suman Jana

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

10 August 2017

published in

Methods in Enzymology

1 reference

10 August 2017

volume

385

1 reference

10 August 2017

page(s)

3-19

1 reference

Glucose transporter gene expression: regulation of transcription and mRNA stability

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Breast cancer: PET imaging of estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Pulmonary abnormalities and PET data analysis: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Analytical decision model for the cost-effective management of solitary pulmonary nodules.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Detection of unknown occult primary tumors using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron emission tomography, bronchogenic carcinoma, and the adrenals

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

18F-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Collaboration system for radiology workstations

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Residual mass in lymphoma may not be residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

FDG PET in the management of lymphoma: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Accuracy of Whole‐Body 18F‐FDP‐PET for Restaging Malignant Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Hippocampal atrophy and T2-weighted signal changes in familial mesial temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Neuroimaging in patients with head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: A study with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Sympathetic cardioneuropathy in dysautonomias

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Abnormalities of Cardiac Sympathetic Innervation in Arrhythmogenic Right Ventricular Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Longitudinal follow-up in 145 patients with medically refractory temporal lobe epilepsy treated surgically between 1984 and 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

PET imaging in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Exclusion of Chronic Osteomyelitis With F-18 Fluorodeoxyglucose Positron Emission Tomographic Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

5. Utility of F-18 FDG Imaging for Diagnosing the Infected Joint Replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Infection imaging using whole-body FDG-PET

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Value of FDG PET in patients with fever of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

P-glycoproteins: mediators of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Visualization of multidrug resistance in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Kinetics of [methyl-11C]thymidine in patients with squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]Iodoerythronitroimidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Will imaging of apoptosis play a role in clinical care? A tale of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

In vivo detection and imaging of phosphatidylserine expression during programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Molecular imaging: exploring the next frontier

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

New approaches for imaging in gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

Radiopharmaceuticals for the study of inflammatory processes: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2804%2985001-8

7 January 2021

10.1016/S0076-6879(04)85001-8

Identifiers

DOI

1 reference

10 August 2017

1 reference